Quest Diagnostics Inc <DGX.N>: Truist Securities raises target price to $260 from $250
DGX•Related News
FDA grants priority review to Insmed ARIKAYCE MAC lung disease sNDA, PDUFA set for Jan. 28, 2027
INSM•
Wesco International: Distribution Amends Revolving Credit Facility On Sept 17, 2026
WCC•
JPMorgan, Qatar's Qia Target $20 Billion Investment Partnership - Bloomberg News
JPM•
Agios Pharmaceuticals, Inc. <AGIO.O>: Bofa Global Research Raises Price Objective to $50 from $46
AGIO•
New Era Energy & Digital signs 20-year power supply deal with Vistra for up to 207 MW Texas data center project
NUAI•